Skip to main
WBA
WBA logo

Walgreens (WBA) Stock Forecast & Price Target

Walgreens (WBA) Analyst Ratings

Based on 25 analyst ratings
Hold
Strong Buy 8%
Buy 12%
Hold 60%
Sell 16%
Strong Sell 4%

Bulls say

Walgreens Boots Alliance operates over 8,000 retail pharmacy locations across the U.S., serving nearly three-quarters of Americans within a five-mile radius, generating approximately two-thirds of its revenue from prescription drug sales. The company's diverse revenue streams, including retail products and healthcare services, position it as a comprehensive healthcare provider while enhancing its omnichannel experience through initiatives like Health Corner and Village Medical. Additionally, ongoing investments in services, a focus on improving free cash flow, and strategic debt management signal a strong potential for long-term growth in a rapidly evolving retail and healthcare landscape.

Bears say

Walgreens Boots Alliance faces significant downside risks, including increased pricing pressure and a deteriorating retail environment, which could adversely affect its revenue streams. The company is experiencing weak cash flow and slower growth in the U.S., prompting management to suspend its quarterly cash dividend as part of a strategic capital allocation adjustment. These factors contribute to an overall negative outlook for the stock, highlighting concerns over its financial stability and future performance.

Walgreens (WBA) has been analyzed by 25 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 12% recommend Buy, 60% suggest Holding, 16% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Walgreens and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Walgreens (WBA) Forecast

Analysts have given Walgreens (WBA) a Hold based on their latest research and market trends.

According to 25 analysts, Walgreens (WBA) has a Hold consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $34.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $34.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Walgreens (WBA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.